Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study

Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study

Purpose: Although aspirin therapy is used widely in older adults for prevention of cardiovascular disease, its impact on the incidence, progression and severity of age-related macular degeneration (AMD) is uncertain. The effect of low-dose aspirin on the course of AMD will be evaluated in this clini...

Full description

Bibliographic Details
Main Authors: Liubov Robman, Robyn Guymer, Robyn Woods, Stephanie Ward, Rory Wolfe, James Phung, Lauren Hodgson, Galina Makeyeva, Khin Zaw Aung, Tom Gilbert, Jessica Lockery, Y-Anh Le-Pham, Suzanne Orchard, Elsdon Storey, Walter Abhayaratna, Daniel Reid, Michael E. Ernst, Mark Nelson, Christopher Reid, John McNeil
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Contemporary Clinical Trials Communications
Subjects:
Age-related macular degeneration
AMD
Aspirin
Incidence
Progression
Randomized controlled trial
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865416301156

Similar Items

Similar Items